Sling Therapeutics Appoints Raymond Douglas, M.D., Ph.D., as Chief Scientific Officer
– Dr. Raymond Douglas, renowned thyroid eye disease specialist, joins the management team and brings extensive clinical and development experience across the spectrum of TED therapies – – Appointment supports the development of company’s lead asset, linsitinib, through the ongoing Phase…